UK News ‘Bumpy periods’ predicted but vaccine hailed for impact on infections and deaths
COVID-19: Good news for the Sanofi Pasteur
Vaccine © Neovacs Covid-19: Good news for the Sanofi Pasteur vaccine The European Medicines Agency announced the launch of a "continuous review procedure "The vaccine. A new Vaccine against Cvid-19, French, which is, will it soon arrive on the European market? A few steps remain to cross, but a good news fell for the Sanofi Pasteur vaccine.
Covid vaccines are estimated to have prevented an estimated 22 million infections and 60,000 deaths in England.
Figures from Public Health England (PHE) also suggest jabs are estimated to have directly averted more than 52,600 hospital admissions.
The figures were published as England’s deputy chief medical officer, Professor Jonathan Van-Tam, said he hopes the worst of the pandemic is behind us but warned there could be “one or two bumpy periods” ahead.
The statistics cover the period up to July 23 and are based on modelling by PHE and Cambridge University.
Previous estimates, for the period up to July 9, had suggested about 37,000 deaths and 11 million infections had been prevented.
Pregnant women are now urged to get Covid jab
New Public Health England data shows that so far 51,724 pregnant women in England have received at least one dose, and 20,648 women have had two, around one in ten of all mothers-to-be.Health chiefs said rates of Covid hospitalisations are rising rapidly among unvaccinated mothers-to-be.
The data emerged as the number of people being told to self-isolate reached another record, with almost 700,000 alerts sent to Covid app users in England and Wales.
The so-called “pingdemic” saw 689,313 alerts sent to users of the NHS Covid-19 app last week telling them they had been in close contact with someone who had tested positive for coronavirus.
The figures, for the week to July 21, are an 11% rise on the previous record of 619,733 alerts a week earlier.
Elsewhere, the Government confirmed there had been a further 31,117 lab-confirmed Covid-19 cases in the UK, as of 9am on Thursday.
A further 85 people had died within 28 days of testing positive for Covid-19 as of Thursday, bringing the UK total to 129,515.
Separate figures published by the Office for National Statistics (ONS) show there have been 154,000 deaths registered in the UK where Covid-19 was mentioned on the death certificate.
COVID cases in UK fall for seventh day in a row - but number of new deaths highest since mid-March
The UK has recorded 23,511 new COVID-19 cases and 131 more coronavirus-related deaths in the latest 24-hour period, according to government data. © PA The number of new COVID-related deaths in the UK is the highest since 17 March. File pic It is the seventh day in a row that the number of infections has fallen.But it is the highest number of daily deaths since 17 March, when 141 fatalities were reported.It takes the total number of people who have died in the UK within 28 days of a positive COVID test to 129,303.
The blitz of new statistics and estimates come amid uncertainty over how the pandemic will unfold in the coming weeks.
Prof Van-Tam disputed a claim made by a senior minister earlier this week that Covid was “all over bar the shouting” after cases dropped sharply this month.
The medical officer told BBC News: “I wish it were so. This is not all over bar the shouting.
Video: Cancer report (The Independent)
“I hope the worst is behind us but I think it’s quite possible that we’re going to have one or two bumpy periods in the autumn and in the winter, not only through Covid, but also through flu and other respiratory viruses as well.”
He said lockdowns last winter had “completely shut out pretty much all of the other respiratory viruses” which could re-emerge this year.
AstraZeneca vaccine 'has same risk of blood clots as Pfizer's'
Pfizer's coronavirus vaccine is just as likely to trigger blood clots as AstraZeneca's, according to a study in Spain that has prompted fury among UK Government officials. Scientists compared rates of thrombosis among more than 1.3million recipients of either jab in Spain. Both vaccines came with a tiny risk of causing blood clots, with scientists branding their safety profiles 'broadly similar'. Pfizer's jab may even be more likely to trigger the rare blood-clotting complication, the data suggested. In contrast, the virus itself was eight times more likely to lead to thromboembolism than either jab.
This week the Government said it was expanding daily contact testing for frontline sector workers who are exempt from isolation.
Downing Street has confirmed 260 testing sites are open, while 800 more are “in the process” of being set up for support workers in critical industries.
A spokesman for the Prime Minister said: “Following them, we will then establish the remaining 1,200 over the coming days.”
Daily negative test results will enable eligible workers, including those in prisons, waste collection, defence, the food industry, transport, Border Force and police and fire services, who have been alerted by the NHS Covid-19 app or called by NHS Test and Trace as coronavirus contacts to continue working.
Communities Secretary Robert Jenrick urged people to isolate if they are advised to do so, saying there “isn’t very long to go” until August 16 when all fully vaccinated contacts who test negative can avoid isolation.
But one in four young adults who test positive no longer follow the rules for self-isolating, a survey published on Thursday suggested.
Covid-19: Israel authorizes a third dose of vaccine against the increasing cases
© AFP - EMMANUEL DUNAND A person over 60 years is to inject a third dose of Pfizer vaccine Biontech in Tel Aviv 30 July 2021 the epidemic continues to grow in many countries, particularly because of varying Delta is more contagious. Faced with an increase in its territory, the Israeli government has launched a campaign injection of a third dose of vaccine for people over 60 years.
The ONS found that 75% of respondents aged between 18 and 34 said they fully adhered to isolation requirements for the entire 10-day period after testing positive for coronavirus.
This was “statistically significantly” lower than the percentage of 35 to 54-year-olds who said they followed the rules (86%), according to the ONS, whose figures are based on responses collected from adults in England between July 5 and 10.
While there is a legal duty in England for people to self-isolate if they test positive or are contacted by NHS Test and Trace, this does not extend to notifications from the app, although the Government strongly advises people to do so.
The latest Test and Trace figures showed the proportion of people not being reached by the scheme to provide details of recent close contacts has hit the highest level for nine months, at 14.8%.
The number of people testing positive in England in the week to July 21 reached 307,758, up 18% on the previous week and the highest number since January 13, according to the figures.
Meanwhile the easing of restrictions for EU and US travellers coming to England has been defended as a “smart, sensible” approach by the Government, amid concerns about the risk of a new variant emerging.
Foreign Secretary Dominic Raab said he is confident it is the right step and described the new rules as a “modest opening up”.
From 4am on Monday, England is to allow people visiting from the US and the EU who are fully vaccinated against coronavirus to enter without the need to quarantine.
Labour has claimed there is a risk of allowing a new Covid variant to “run rampant” through the country, and it has been reported the Cabinet had been warned the move posed a “clear public health risk”.
COVID-19. The European Commission Announces Early Vaccine Purchase Agreement with Novavax .
© Reuters / Dado RUVIC / Illustration / File Photo A woman holds a small bottle labeled with a sticker "Coronavirus Covid-19 Vaccine" and a medical syringe in front of the Logo Novavax displayed in this photo Illustration taken on October 30, 2020. The European Commission announced this Wednesday 4 August having an agreement with the American company Novavax for an anticipated purchase of 200 million doses of its VVID-19 vaccine.